Idera Pharmaceuticals, Inc.

États‑Unis d’Amérique

Retour au propriétaire

1-8 de 8 pour Idera Pharmaceuticals, Inc. Trier par
Recheche Texte
Marque
Affiner par Reset Report
Juridiction
        États-Unis 4
        Canada 2
        Europe 1
        International 1
Classe NICE
05 - Produits pharmaceutiques, vétérinaires et hygièniques 7
42 - Services scientifiques, technologiques et industriels, recherche et conception 5
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture 2
44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture. 2
Résultats pour  marques

1.

IDERA

      
Numéro de série 88631158
Statut Enregistrée
Date de dépôt 2019-09-25
Date d'enregistrement 2020-12-15
Propriétaire Idera Pharmaceuticals, Inc. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Medical therapeutic preparations, namely, biologically active modulators, biologically active immune modulators, biologically active antisense DNA or RNA compounds, chemical modulators of gene expression working at DNA transcription, RNA or translation processes; immunomodulatory oligonucleotides, namely, ingredients that enhance or induce an immune response as a component part in a pharmaceutical preparation; pharmaceutical and vaccine adjuvants to enhance the immune system response; pharmaceuticals for use in the treatment of viral and bacterial infection, inflammatory disorders and diseases, cancer, and auto immune diseases and disorders and vaccine adjuvants to modulate the immune system; biologically active pharmaceutical compounds for use in the treatment of viral and bacterial infection or diseases associated with cellular gene expressions by preventing the production of disease associated proteins made by said infectious agents or cellular genes

2.

IDERA

      
Numéro d'application 176194800
Statut Enregistrée
Date de dépôt 2016-01-05
Date d'enregistrement 2019-07-26
Propriétaire Idera Pharmaceuticals, Inc. (USA)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

(1) Medical therapeutic preparations, namely, nucleic acids as biologically active modulators, nucleic acids as biologically active immune modulators, biologically active antisense DNA and ribonucleic acid (RNA) compounds, chemical modulators of gene expression, namely reagents for DNA transcription, ribonucleic acid (RNA) and translation processes whereby a protein is synthesized from the information contained in a molecule of messenger RNA (mRNA); immunomodulatory oligonucleotides, namely, ingredients that enhance and induce an immune response as a component part in a pharmaceutical preparation; pharmaceutical and vaccine adjuvants to enhance the immune system response; pharmaceuticals for use in the treatment of viral infections, bacterial infections, inflammatory disorders and inflammatory diseases, namely, anti-infectives and anti-inflammatories; pharmaceuticals for use in the treatment of asthma and allergies, cancer, and auto immune diseases and disorders and vaccine adjuvants to modulate the immune system; biologically active pharmaceutical compounds for use in the treatment of viral and bacterial infection and diseases associated with cellular gene expressions by preventing the production of disease associated proteins made by said infectious agents and cellular genes. (1) Medical research; scientific research in the field of genetics and genetic engineering; biological research in the field of genetics and genetic engineering; chemical research; medical and scientific research in the area of oligonucleotides and chemical products; pharmaceutical research services; pharmaceutical research and development; product research and development for others; biological and chemical research in the field of immunology.

3.

IDERA

      
Numéro d'application 176201000
Statut Enregistrée
Date de dépôt 2016-01-05
Date d'enregistrement 2019-07-26
Propriétaire Idera Pharmaceuticals, Inc. (USA)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

(1) Medical therapeutic preparations, namely, nucleic acids as biologically active modulators, nucleic acids as biologically active immune modulators, biologically active antisense DNA and ribonucleic acid (RNA) compounds, chemical modulators of gene expression, namely reagents for DNA transcription, ribonucleic acid (RNA) and translation processes whereby a protein is synthesized from the information contained in a molecule of messenger RNA (mRNA); immunomodulatory oligonucleotides, namely, ingredients that enhance and induce an immune response as a component part in a pharmaceutical preparation; pharmaceutical and vaccine adjuvants to enhance the immune system response; pharmaceuticals for use in the treatment of viral infections, bacterial infections, inflammatory disorders and inflammatory diseases, namely, anti-infectives and anti-inflammatories; pharmaceuticals for use in the treatment of asthma and allergies, cancer, and auto immune diseases and disorders and vaccine adjuvants to modulate the immune system; biologically active pharmaceutical compounds for use in the treatment of viral and bacterial infection and diseases associated with cellular gene expressions by preventing the production of disease associated proteins made by said infectious agents and cellular genes. (1) Medical and scientific research in the area of oligonucleotides and chemical products; pharmaceutical research and product development for others; biological and chemical research namely in the field of immunology. (2) Medical research; scientific research in the field of genetics and genetic engineering; biological research in the field of genetics and genetic engineering; chemical research; medical and scientific research in the area of oligonucleotides and chemical products; pharmaceutical research services; pharmaceutical research and development; product research and development for others; biological and chemical research in the field of immunology.

4.

IDERA

      
Numéro d'application 909240
Statut Enregistrée
Date de dépôt 2005-11-11
Date d'enregistrement 2005-11-11
Propriétaire Idera Pharmaceuticals, Inc. (USA)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Reagents for the detection of polymerase chain reactions for scientific or research use; diagnostic kits containing a reagent for the detection of polymerase chain reactions for scientific or research use; chemical products, namely, synthetic oligonucleotides for use in the manufacture of pharmaceuticals for modulating the immune system. Medical diagnostic and therapeutic preparations, namely, biologically active modulators, including, immune modulators and antisense DNA or RNA compounds, chemical modulators of gene expression working at DNA transcription, RNA or translation processes; immunomodulatory oligonucleotides namely, ingredients that enhance or induce an immune response as a component part in a pharmaceutical preparation; pharmaceutical and vaccine adjuvants to enhance the immune system response; pharmaceuticals for use in the treatment of viral and bacterial infection, inflammatory disorders and diseases, asthma or allergies, cancer, and auto immune diseases and disorders and vaccine adjuvants to modulate the immune system; biologically active compounds for use in the treatment of viral and bacterial infection or diseases associated with cellular gene expressions by preventing the production of disease associated proteins made by said infectious agents or cellular genes. Medical and scientific services namely provision of care in the field of immunology (terms considered too vague by the International Bureau (Rule 13(2)(b) of the Common Regulations); medical and scientific research in the area of oligonucleotides or chemical products; research and development of pharmaceuticals and research products for others; biological and/or chemical research namely in the field of immunology. Medical services, namely, providing medical care in the field of immunology.

5.

IDERA

      
Numéro d'application 004739868
Statut Enregistrée
Date de dépôt 2005-11-15
Date d'enregistrement 2007-02-23
Propriétaire Idera Pharmaceuticals, Inc. (USA)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Reagents for the detection of polymerase chain reactions for scientific or research use; diagnostic kits containing a reagent for the detection of polymerase chain reactions for scientific or research use; chemical products, namely, synthetic oligonucleotides for use in the manufacture of pharmaceuticals for modulating the immune system. Medical diagnostic and therapeutic preparations, namely, biologically active modulators, including, immune modulators and antisense DNA or RNA compounds, chemical modulators of gene expression working at DNA transcription, RNA or translation processes; immunomodulatory oligonucleotides namely, ingredients that enhance or induce an immune response as a component part in a pharmaceutical preparation; pharmaceutical and vaccine adjuvants to enhance the immune system response; pharmaceutical for use in the treatment of viral and bacterial infection, inflammatory disorders and diseases, asthma or allergies, cancer, and auto immune diseases and disorders and vaccine adjuvants to modulate the immune system; biologically active compounds for use in the treatment of viral and bacterial infection or diseases associated with cellular gene expressions by preventing the production of disease associated proteins made by said infectious agents or cellular genes. Scientific services namely provision of care in the field of immunology; medical and scientific research in the area of oligonucleotides or chemical products; research and development of pharmaceuticals and research products for others; biological and/or chemical research namely in the field of immunology. Medical services, namely, provision of care in the field of immunology.

6.

IDERA

      
Numéro de série 78660228
Statut Enregistrée
Date de dépôt 2005-06-28
Date d'enregistrement 2007-12-04
Propriétaire IDERA PHARMACEUTICALS, INC. ()
Classes de Nice  ? 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Medical and scientific research in the area of oligonucleotides or chemical products; pharmaceutical research and product development for others; biological and chemical research namely in the field of immunology

7.

IDERA

      
Numéro de série 78660224
Statut Enregistrée
Date de dépôt 2005-06-28
Date d'enregistrement 2009-09-15
Propriétaire IDERA PHARMACEUTICALS, INC. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Medical therapeutic preparations, namely, biologically active modulators, biologically active immune modulators, [ biologically active antisense DNA or RNA compounds, ] chemical modulators of gene expression working at DNA transcription, RNA or translation processes; immunomodulatory oligonucleotides, namely, ingredients that enhance or induce an immune response as a component part in a pharmaceutical preparation; pharmaceutical and vaccine adjuvants to enhance the immune system response; pharmaceuticals for use in the treatment of viral and bacterial infection, inflammatory disorders and diseases, asthma or allergies, cancer, and auto immune diseases and disorders and vaccine adjuvants to modulate the immune system; biologically active pharmaceutical compounds for use in the treatment of viral and bacterial infection or diseases associated with cellular gene expressions by preventing the production of disease associated proteins made by said infectious agents or cellular genes

8.

IMO

      
Numéro de série 78277138
Statut Enregistrée
Date de dépôt 2003-07-22
Date d'enregistrement 2008-11-04
Propriétaire IDERA PHARMACEUTICALS, INC. ()
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

immunomodulatory oligonucleotides, namely, ingredients that enhance or induce an immune response as a component part in a pharmaceutical preparation